Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trichomoniasis: What's New?

Karen A. Wendel1

  • 1Division of Infectious Diseases, Oklahoma University Health Science Center, 921 NE 13th Street (111C), Oklahoma City, OK 73104, USA. Karen-wendel@ouhsc.edu

Current Infectious Disease Reports
|March 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Trichomonas vaginalis, a common STD, requires further research into its links with pregnancy complications and HIV. New diagnostic tools and metronidazole resistance studies are crucial for better control.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection globally.
  • Virulence factors enabling host cell adhesion and immune evasion by T. vaginalis have been identified.
  • The precise mechanisms linking trichomoniasis to perinatal morbidity and its interaction with HIV remain unclear.

Purpose of the Study:

  • To investigate the mechanisms behind perinatal morbidity associated with trichomoniasis.
  • To evaluate the complex interactions between trichomoniasis and HIV infection.
  • To assess the efficacy of metronidazole in reducing T. vaginalis-associated perinatal morbidity and explore drug resistance.

Main Methods:

  • Review of current research on T. vaginalis virulence factors and host interactions.

Related Experiment Videos

  • Analysis of studies evaluating metronidazole treatment during pregnancy for trichomoniasis.
  • Discussion of advanced diagnostic methods like polymerase chain reaction (PCR) for epidemiological studies.
  • Examination of data on metronidazole resistance and alternative treatment strategies.

    • Main Results:

    • Metronidazole treatment during pregnancy was unsuccessful in decreasing T. vaginalis-associated perinatal morbidity.
    • Advanced diagnostic tools like PCR show promise for improving epidemiological understanding and disease control.
    • While single-dose metronidazole remains highly effective, concerns about rising drug resistance necessitate further investigation.

    Conclusions:

    • Further research is essential to understand the mechanisms of perinatal morbidity and the interplay between trichomoniasis and HIV.
    • Improved diagnostic sensitivity and ongoing surveillance for metronidazole resistance are critical for effective management and control of Trichomonas vaginalis infections.